Published in Mediators Inflamm on January 01, 2008
Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. J Biol Chem (2009) 0.94
Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene. PLoS Genet (2016) 0.75
Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris. Mediators Inflamm (2017) 0.75
DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING. Proc Soc Exp Biol Med (1964) 3.73
Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med (1990) 2.62
Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis. Arch Dermatol (1991) 1.88
Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest (1997) 1.13
In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis. J Invest Dermatol (2000) 1.12
Pemphigus--diseases of antidesmosomal autoimmunity. JAMA (1999) 1.10
Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients. Lupus (2006) 1.01
Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy. Cytokine (2008) 0.99
Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur Cytokine Netw (1997) 0.96
Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol (1992) 0.95
Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. Clin Immunol (2001) 0.93
Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines. Eur Cytokine Netw (1994) 0.92
Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab. Br J Dermatol (2005) 0.91
Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis. Exp Dermatol (2003) 0.91
Synergistic actions of pemphigus vulgaris IgG, Fas-ligand and tumor necrosis factor-alpha during induction of basal cell shrinkage and acantholysis. Autoimmunity (2006) 0.87
High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors. Eur J Immunol (2004) 0.87
TNFalpha and IL-6 are mediators in the blistering process of pemphigus. Int J Dermatol (2001) 0.86
Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers. Clin Immunol (2006) 0.85
A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice. Br J Dermatol (2004) 0.85
ICAM-1, ELAM-1, TNF-alpha and IL-6 in serum and blister liquid of pemphigus vulgaris patients. Roum Arch Microbiol Immunol (2002) 0.85
A model for the study of autoimmune diseases applied to pemphigus: transplants of human oral mucosa to athymic nude mice binds pemphigus antibodies in vivo. J Invest Dermatol (1981) 0.84
Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Cytokine (2000) 0.82
In vitro C3 mRNA expression in Pemphigus vulgaris: complement activation is increased by IL-1alpha and TNF-alpha. J Cutan Med Surg (1999) 0.80
The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy. Curr Eye Res (2007) 0.78
Lupus vulgaris: report of two cases. Int J Dermatol (2005) 1.19
The effect of chronic ultraviolet radiation on the human immune system. Photochem Photobiol (2008) 1.19
Increased cystatin C concentration in urine of nephrotic children. Pediatr Nephrol (2004) 1.16
Environmental risk factors predisposing to the development of basal cell carcinoma. Dermatol Surg (2004) 1.11
1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin. Pol J Pharmacol (2003) 1.07
The number and distribution of blood dendritic cells in the epidermis and dermis of healthy human subjects. Folia Histochem Cytobiol (2006) 1.03
Dermatitis artefacta in a patient with paranoid syndrome. Acta Dermatovenerol Alp Pannonica Adriat (2007) 0.93
Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus. Eur Cytokine Netw (2004) 0.91
Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis. Exp Dermatol (2011) 0.90
Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations. Clin Rheumatol (2010) 0.90
The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population. Cell Mol Biol Lett (2004) 0.89
Persistent improvement of previously recalcitrant Hailey-Hailey disease with electron beam radiotherapy. Acta Derm Venereol (2010) 0.88
Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients. Mediators Inflamm (2003) 0.87
The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis. Mediators Inflamm (2009) 0.86
Acetylation genotype and phenotype in patients with systemic lupus erythematosus. Pharmacol Rep (2006) 0.86
Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients. Mediators Inflamm (2005) 0.85
Effective treatment of nodular amyloidosis with carbon dioxide laser. J Cutan Med Surg (2012) 0.85
Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome. Am J Nephrol (2007) 0.85
Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development? Arch Dermatol Res (2007) 0.85
An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes. Exp Dermatol (2011) 0.85
[Medical and legal aspects of smoking]. Pol Merkur Lekarski (2012) 0.84
Protective effect of the KIR2DS1 gene in atopic dermatitis. Gene (2013) 0.84
Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus. Eur Cytokine Netw (2007) 0.83
Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus. Eur Cytokine Netw (2002) 0.83
[Quality of life predictors among patients suffering from systemic lupus erythematosus]. Przegl Lek (2006) 0.82
Vitamin D serum level changes in psoriatic patients treated with narrowband ultraviolet B phototherapy are related to the season of the irradiation. Photodermatol Photoimmunol Photomed (2011) 0.82
[Prevalence of autoantibodies directed against 1,25(OH)2D3 in patients with systemic lupus erythematosus]. Pol Merkur Lekarski (2010) 0.81
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis. Clin Rheumatol (2006) 0.81
Risk factors in Central Poland for the development of superficial and nodular basal cell carcinomas. Arch Med Sci (2010) 0.80
[Neurological disorders in systemic lupus erythematosus patients]. Pol Merkur Lekarski (2009) 0.80
[Concentration of selected cytokines in serum of patients with acne rosacea]. Przegl Lek (2008) 0.80
Repeated suberythemal UVB preexposure protects against high-dose UVB-induced expression of vitamin D receptor protein in human Skin. J Invest Dermatol (2011) 0.80
Pathogenic activity of circulating anti-desmoglein-3 autoantibodies isolated from pemphigus vulgaris patients. Arch Med Sci (2012) 0.80
IL-17 expression in dermatitis herpetiformis and bullous pemphigoid. Mediators Inflamm (2013) 0.80
Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin Rheumatol (2006) 0.80
Clinical and psychological characteristics of patients with psoriasis reporting various frequencies of pruritus. Int J Dermatol (2013) 0.80
Interleukin 4 plasma levels in psoriasis vulgaris patients. Med Sci Monit (2004) 0.79
Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients. Eur Cytokine Netw (2013) 0.79
The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis. Mediators Inflamm (2005) 0.79
Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis. Mediators Inflamm (2006) 0.79
Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. J Invest Dermatol (2011) 0.78
Plaque form of warty dyskeratoma - acantholytic dyskeratotic acanthoma. J Cutan Pathol (2007) 0.78
Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients. Arch Dermatol Res (2012) 0.78
Repeated doses of UVR cause minor alteration in cytokine serum levels in humans. Mediators Inflamm (2005) 0.78
Serum levels of tissue inhibitor of metalloproteinases 2 in systemic sclerosis: a preliminary study. Med Sci Monit (2002) 0.77
Lack of effect of repeated suberythemal ultraviolet-B exposures on human blood dendritic subtypes. Photodermatol Photoimmunol Photomed (2005) 0.77
Early cardiovascular involvement in patients with systemic sclerosis (SSc). Med Sci Monit (2002) 0.77
Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoid. Pol J Pathol (2006) 0.77
[Drug eruptions]. Przegl Lek (2002) 0.77
Expression of selected ADAMs in bullous pemphigoid and dermatitis herpetiformis. J Dermatol Sci (2009) 0.77
Association of Trp64Arg polymorphism of beta3-adrenergic receptor with insulin resistance in Polish children with obesity. J Pediatr Endocrinol Metab (2008) 0.77
Increased cyclooxygenase expression and thymine dimer formation after repeated exposures of humans to low doses of solar simulated radiation. Exp Dermatol (2007) 0.77
Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration. Rheumatol Int (2010) 0.77
[Scleroderma-like lesions in the course of autoimmune hepatitis. Case report]. Przegl Lek (2005) 0.77
The effect of repeated exposures to low-dose UV radiation on the apoptosis of peripheral blood mononuclear cells. Arch Dermatol (2009) 0.76
Expression of selected adhesion molecules in dermatitis herpetiformis and bullous pemphigoid. Pol J Pathol (2009) 0.76
Vitamin D Receptor Gene BsmI Polymorphism in Polish Patients with Systemic Lupus Erythematosus. ISRN Endocrinol (2013) 0.76
[Quality of life in patients with rosacea]. Przegl Lek (2008) 0.76
Detection of pemphigus autoantibodies by IIF and ELISA tests in patients with pemphigus vulgaris and foliaceus and in healthy relatives. Med Sci Monit (2003) 0.76
Nitric oxide levels in plasma and fibroblast cultures of psoriasis vulgaris patients. J Dermatol Sci (2007) 0.75
Genetic polymorphisms of CYP2D6 oxidation in patients with autoimmune bullous diseases. Postepy Dermatol Alergol (2013) 0.75
The -1154 G/A VEGF gene polymorphism is associated with the incidence of basal cell carcinoma in patients from northern Poland. Arch Dermatol Res (2014) 0.75
Expression of selected integrins and selectins in bullous pemphigoid. Mediators Inflamm (2007) 0.75
Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement. Mediators Inflamm (2003) 0.75
Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus. Mediators Inflamm (2003) 0.75
[Chloroquine influence on lipid metabolism and selected laboratory parameters]. Przegl Lek (2005) 0.75
[Diagnostic methods of central nervous system changes in SLE patients]. Przegl Lek (2005) 0.75
[Acne rosacea--diagnostic challenge]. Przegl Lek (2006) 0.75
Suppression of contact hypersensitivity after repeated exposures of humans to low doses of solar simulated radiation. Photochem Photobiol Sci (2005) 0.75
Sonic hedgehog pathway dysregulation in skin basal-cell carcinoma of a Polish population. Folia Histochem Cytobiol (2013) 0.75
[Quality of life in systemic lupus erythematosus patients, with a particular description of methodology]. Postepy Hig Med Dosw (Online) (2007) 0.75
[The role of endothelial cells in the pathogenesis of systemic lupus erythematosus]. Postepy Hig Med Dosw (Online) (2007) 0.75
[Progress and perspectives in the treatment of systemic lupus erythematosus]. Przegl Lek (2005) 0.75
Contact Hypersensitivity to European Baseline Series and Corticosteroid Series Haptens in a Population of Adult Patients with Contact Eczema. Acta Dermatovenerol Croat (2016) 0.75
Repeated exposures of humans to low doses of solar simulated radiation lead to limited photoadaptation and photoprotection against UVB-induced erythema and cytokine mRNA up-regulation. J Dermatol Sci (2006) 0.75
[Proinflammatory cytokines in inactive lupus erythematosus patients]. Przegl Lek (2005) 0.75
[Usefulness of ultraviolet radiation in dermatological treatment]. Przegl Lek (2002) 0.75
Histological examination in assessment of ultraviolet-induced suppression of contact hypersensitivity response. Pol J Pathol (2005) 0.75
ICOS gene polymorphism may be associated with pemphigus. J Cutan Med Surg (2010) 0.75